3 news items
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
BYSI
3 May 24
is a co-investigator on several peer-reviewed research projects and has authored numerous publications and abstracts in Hematology and Oncology. Dr
BeyondSpring Doses First Patient With Pembrolizumab, Plinabulin Plus Etoposide/Platinum In A Phase 2 Investigator-Initiated Study Of First-Line Extensive-Stage Small-Cell Lung Cancer
BYSI
25 Mar 24
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
BYSI
25 Mar 24
on developing innovative cancer therapies, today announced that the first patient has been dosed in a Phase 2 investigator-initiated trial (IIT
- Prev
- 1
- Next